Tuesday, August 1, 2000
fesub.gif (4328 bytes)
Full Story
 Intel IT update
fe.gif (834 bytes)
India's first e-business paper
flnews.gif (5153 bytes)
Search FE
-
Download
BSE Quotes
NSE Quotes
-
Think Tank
This week we focus on a complete analysis of the
india’s external debt industry
-
 

Dabur net profit jumps 35 per cent to Rs 7.16 crore in first-quarter 

Pummy Kaul  
New Delhi, July 31: Dabur India Limited, today, recorded an increase of 35 per cent in its net profit to Rs 7.16 crore for the first quarter ended June 2000 up from Rs 5.27 crore during the same quarter in 1999. The net profit excludes a non-recurring income of Rs 21.17 crore received by the company from sale of its 49 per cent stake in General de Confetria Ltd during the same period last year. The sales turnover grew by 6.2 per cent to Rs 247.90 crore as against Rs 233.53 crore during the period under the review.

However, according to the company release, the sales turnover went up by 10 per cent on like to like basis after excluding its foods business that has been carved into a separate subsidiary. The company expects to record higher growth rates during the rest of the year as some new products are slated for launch during the second and third quarter. Recently, Dabur added a new variant to its Pudin Hara range. The board also approved a stock split of each equity share of Rs 10 into 10 equity shares of Re 1 which would lead to an increase in the number of shares of the company resulting in better liquidity. As a step towards professionalisation of Dabur's board, Dabur inducted SM Datta and Sunil Duggal on the board of directors. While Datta has formerly been the chairman of Hindustan Lever Ltd (HLL), Duggal is the vice president-family products division, Dabur.

The company has maintained its advertising and promotional expenditure at 11.5 per cent of sales and recorded healthy growth in the sales performance of some of its major health and personal care brands. While Vatika shampoo grew by more than 100 per cent, Dabur Amla Hair Oil, Special Hair Oil and Dabur Honey by 12 per cent, Hajmola by 13 per cent and Ulgel, an antacid in ethnic flavours increased by 20 per cent.

It's key pharmaceutical brand New Livfit recorded a growth of more than 100 per cent, the release added. During the quarter, the company made an additional investment of $ 3 million in Dabur Oncology plc, the subsidiary set up in the UK to manufacture and market oncology formulations for European and US markets.

Copyright © 2000 Indian Express Newspapers (Bombay) Ltd.

- Lead Stories | Corporate | Infrastructure | Commodities | Economy/Finance | BSE Today | NSE/ Markets | Strategy | Convergence | After Hours top.gif (150 bytes)Top
flame.jpg (1068 bytes) © Copyright 1999: Indian Express Newspaper(Bombay) Ltd. All rights reserved throughout the world.
This entire edition is compiled in Mumbai by The Indian Express Online Media Limited, a division of
The Indian Express Group of Newspapers. Managed by The Indian Express Online Media Limited and hosted by CerfNet.